FDA Issues Voluntary Recall of Blood Pressure Medication Due to Cancer Concerns

FDA recalls blood pressure medication due to possible risk of cancer

FDA recalls blood pressure medication due to possible risk of cancer

In total, the recall encompasses less than 1% of the national losartan drug products. This is another drug, which gets used by heart patients and they have also been under a recall since the month of July. The tablets are produced by Lek Pharmaceuticals dd in Ljubljana, Slovenia.

The company is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg. They come in 1000-count plastic bottles labeled NDC 0781-5207-10 with a lot number of JB8912. Sandoz has not received any reports that the affected blood pressure medication caused an adverse reaction to anyone. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC).

This product was distributed nationwide to distributors. This product was distributed nationwide to distributors after October 8.

Sandoz has notified distributors and patients in a letter of the recall.

This is the third blood pressure medication to face recall as of late. Many more were announced in August as the recall spread to Canada and the European Union.

People with questions may contact Sandoz Inc.at 800-525-8747, Monday through Friday from 8:30 a.m.to 5 p.m. ET, or email [email protected] Contact your doctor or pharmacist to discuss alternative treatments.

Patients who are now on the medication are advised to talk to their doctor before stopping use. The Administration has a current list of products, which are recalled and also a list of valsartan products, which have not been recalled.

I Answered Mueller's Questions, Not Submitted Them
Pokemon Let's Go: How To Get Bulbasaur, Charmander, And Squirtle